ResearcherPeking University First HospitalNo recent work listed

Xu Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4499-2331; OpenAlex author ID A5100437322. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 2

[Current status and prospects of neoadjuvant therapy for resectable pancreatic cancer]. Co-author DOI 10.3760/cma.j.cn112139-20230510-00199 ↗
Application of Single-Cell RNA Sequencing in Pancreatic Cancer and the Endocrine Pancreas. Co-author DOI 10.1007/978-981-15-4494-1_12 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yinmo Yang · 1 shared paper, 2023 · strength 0.26
- Paper [Current status and prospects of neoadjuvant therapy for resectable pancreatic cancer]. DOI 10.3760/cma.j.cn112139-20230510-00199 ↗
Xiaodong Tian · 1 shared paper, 2023 · strength 0.26
- Paper [Current status and prospects of neoadjuvant therapy for resectable pancreatic cancer]. DOI 10.3760/cma.j.cn112139-20230510-00199 ↗
Tao Qin · 1 shared paper, 2020 · strength 0.15
- Paper Application of Single-Cell RNA Sequencing in Pancreatic Cancer and the Endocrine Pancreas. DOI 10.1007/978-981-15-4494-1_12 ↗
Qiankun Luo · 1 shared paper, 2020 · strength 0.15
- Paper Application of Single-Cell RNA Sequencing in Pancreatic Cancer and the Endocrine Pancreas. DOI 10.1007/978-981-15-4494-1_12 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.